- SUPN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Supernus Pharmaceuticals (SUPN) 8-K9 Feb 21Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric PatientsFinancial data
Company Profile